Three Seasons Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Sell
1,810
-108
-6% -$110K 0.2% 42
2026
Q1
$1.76M Sell
1,918
-75
-4% -$76K 0.67% 42
2025
Q4
$2.14M Buy
1,993
+146
+8% +$140K 0.2% 31
2025
Q3
$1.41M Buy
1,847
+319
+21% +$237K 0.14% 37
2025
Q2
$1.19M Sell
1,528
-182
-11% -$141K 0.14% 26
2025
Q1
$1.41M Buy
1,710
+773
+82% +$643K 0.7% 24
2024
Q4
$723K Buy
937
+445
+90% +$368K 0.35% 57
2024
Q3
$436K Buy
492
+51
+12% +$45.9K 0.23% 80
2024
Q2
$399K Buy
441
+19
+5% +$15.2K 0.22% 69
2024
Q1
$322K Sell
422
-1,897
-82% -$1.35M 0.23% 65
2023
Q4
$1.35M Buy
+2,319
New +$1.35M 1.19% 31

Other funds holding LLY

Three Seasons Wealth's LLY Position: Q2 2026 in Review

Three Seasons Wealth reduced its Eli Lilly (LLY) stake by 5.6% in Q2 2026, selling an estimated $110K and leaving 1,810 shares worth $2.17M. The position accounts for 0.2% of the portfolio, ranked #42.

Three Seasons Wealth first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Three Seasons Wealth held 1,810 shares of Eli Lilly worth $2.17M as of Q2 2026.
  • Three Seasons Wealth sold 108 Eli Lilly shares in Q2 2026, an estimated $110K.
  • Eli Lilly made up 0.2% of Three Seasons Wealth's portfolio in Q2 2026, its #42 holding.
  • Three Seasons Wealth first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Three Seasons Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.